Skip to main content
. 2023 Jun 22;67(7):e00194-23. doi: 10.1128/aac.00194-23

FIG 2.

FIG 2

Cefiderocol MIC distribution of 46 multidrug- or carbapenem-resistant Pseudomonas aeruginosa isolates treated with cefiderocol under the compassionate use program. CLSI, Clinical and Laboratory Standards Institute; FDA, U.S. Food and Drug Administration.